“How is Prostate Cancer Detected?” featuring Drs. Tewari and Schlegel (ProstateCancerMD)
Posted by admin on Sep 7, 2009 under Prostate Cancer Antigen
“PSA allows us to detect prostate cancer several years before that nodule would develop, at a much earlier stage, and therefore at a much more curable stage.” Drs. Schlegel (Department Chairman) and Tewari of Cornell Urology discuss the application of PSA tests, digital rectum exams, and other approaches that enable urologists to diagnose prostate cancer earlier. A family history of prostate cancer and the implications relative to a diagnosis of prostate cancer is also discussed. The need to receive a PDA and at what age is also covered by one of the leading prostate cancer researchers.
Duration : 0:1:25
Drawing on his expertise as a prostate specialist, as well as his experience as a prostate cancer patient, Dr. Bans has developed a 30-minute educational DVD entitled “Your Prostate Biopsy is Positive: Here’s What You Should Know.”
“There’s no doubt that if the cancer is picked up early, it gives many more treatment options than if it’s picked up later.” Dr. Tewari (leader in prostate cancer research and surgery) of Cornell Urology discusses the critical importance of early detection in prostate cancer and the benefits it has for prostate cancer patients.
“The most important thing to prevent prostate cancer is to pick your parents properly.” Dr. Schlegel (Department Chairman) of Cornell Urology discusses a question they face often—Can prostate cancer be prevented? They discuss the role of race, diet, genetic profile and review important steps we can take to decrease our risk of facing prostate cancer.
Dr. Briers is Founder and General Director of Beta Ventures a publisher, congress organiser and business consulting firm providing information, journals, further training and services for clinical biologists and the diagnostic and medical industry. 
“It’s like poking into a pillow in which a couple of golf balls are hidden.” Dr. Tewari, of the Dept. of Urology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, discusses the prostate cancer biopsy and its effectiveness. While it’s the best they have, it is not perfect.
In this health video minute on prostate cancer, Drs. Tewari (leader in prostate cancer research and surgery) and Schlegel (Department Chairman) of Cornell Urology provide an overview of the advanced surgical techniques that help patients avoid some of the complications ociated with complicated prostate cancer surgery treatment options. Discussions concerning erectile dysfunction and urinary incontinence resulting from prostate cancer surgery are among the potential complications these leaders in prostate cancer surgery and research discuss.
Barry Broughton is a successful marketing executive who has traveled the world and faced a lifetime of challenges. But few challenges would be as difficult as the diagnosis he received last year of prostate cancer. Barrys cancer was diagnosed following a test called a PSA, or prostate-specific antigen test, which measures a protein produced by the prostate that is elevated in most men with prostate cancer. A rising PSA indicates the likelihood of a growing cancer, and the faster it rises, the more aggressive the cancer is likely to be.
Michael Cohen, MD from Lawrenceville Urology (www.lawrencevilleurology.com) and Capital Health (www.capitalhealth.org) in Trenton, NJ discusses prostate cancer screening and prostate cancer treatments options including robotic daVinci prostatectomy and robotic Cyberknife radiation therapy.
“The outcomes from surgical treatment of prostate cancer are dependent on the patient’s age, on the extent of the tumor, and to some degree the experience and results that an individual surgeon gets.” Dr. Schlegel, of the Dept. of Urology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, explains common expectations for patients entering into prostate cancer surgery and what factors those expectations are founded upon.